Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw purchased 21,142 shares of the firm’s stock in a transaction that occurred on Wednesday, October 23rd. The shares were acquired at an average price of $0.74 per share, for a total transaction of $15,645.08. Following the completion of the transaction, the chief executive officer now owns 14,794,794 shares in the company, valued at $10,948,147.56. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.
Retractable Technologies Stock Down 1.0 %
Shares of RVP opened at $0.73 on Friday. The firm has a market capitalization of $21.93 million, a price-to-earnings ratio of -2.82 and a beta of 2.06. Retractable Technologies, Inc. has a 52 week low of $0.71 and a 52 week high of $1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The business’s fifty day moving average price is $0.85 and its two-hundred day moving average price is $1.00.
Retractable Technologies (NYSE:RVP – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The business had revenue of $6.03 million for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.
Institutional Trading of Retractable Technologies
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on Retractable Technologies in a research report on Friday, October 18th. They issued a “hold” rating on the stock.
Get Our Latest Stock Analysis on Retractable Technologies
About Retractable Technologies
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Recommended Stories
- Five stocks we like better than Retractable Technologies
- How to Find Undervalued Stocks
- Rocket Lab Stock Soars Higher: Can It Keep Climbing?
- 10 Best Airline Stocks to Buy
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How to invest in marijuana stocks in 7 stepsĀ
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.